Cell Marque
Bajo pedido
BCA-225
Anti-BCA-225 primary antibody labels breast cancer antigen 225 (BCA-225) in primary and metastatic breast carcinoma. BCA -225 was first identified in T47D breast carcinoma cells, but its expression in other carcinomas such as lung, kidney, ovary and endometrium has also been demonstrated. 1-4 BCA-225 expression has also been found in sebaceous gland tumors.5,
Datos técnicos
- Reactividad
- paraffin
- Visualización
- cytoplasmic
- Control
- breast carcinoma
- Estabilidad
- up to 36 mos. at 2-8°C